These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 415471)

  • 1. Prolactin-lowering effect of low doses of lisuride in man.
    Horowski R; Wendt H; Gräf KJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):234-40. PubMed ID: 415471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of lisuride hydrogen maleate in the hyperprolactinaemia-amenorrhoea syndrome: clinical and hormonal responses.
    De Cecco L; Foglia G; Ragni N; Rossato P; Venturini PL
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):491-8. PubMed ID: 106990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of lactation with lisuride.
    Hardt W; Schmidt-Gollwitzer M; Horowski R
    Gynecol Obstet Invest; 1979; 10(2-3):95-105. PubMed ID: 535777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lisuride on serum prolactin levels during puerperium.
    Venturini PL; Maganza C; Massimilla A; Campanella P; Rossato P; Ragni N; De Cecco L
    Acta Eur Fertil; 1979 Jun; 10(2):51-5. PubMed ID: 545976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lisuride on inhibition of lactation and serum prolactin.
    De Cecco L; Venturini PL; Ragni N; Rossato P; Maganza C; Gaggero G; Horowski R
    Br J Obstet Gynaecol; 1979 Nov; 86(11):905-8. PubMed ID: 508675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
    Venturini PL; Horowski R; Maganza C; Morano S; Pedretti E; Ragni N; Semino F; De Cecco L
    Eur J Obstet Gynecol Reprod Biol; 1981 May; 11(6):395-400. PubMed ID: 7018950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay of plasma lisuride in man following intravenous and oral administration of lisuride hydrogen maleate: effect on plasma prolactin level.
    Hümpel M; Nieuweboer B; Hasan SH; Wendt H
    Eur J Clin Pharmacol; 1981; 20(1):47-51. PubMed ID: 7308272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metoclopramide and lisuride on hypophyseal and gonadal function in men.
    Gräf KJ; Schmidt-Gollwitzer M; Horowski R; Dorow R
    Clin Endocrinol (Oxf); 1982 Sep; 17(3):243-51. PubMed ID: 6819898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the ergot derivative lisuride hydrogen maleate on serum prolactin concentrations in female rats.
    Gräf KJ; Neumann F; Horowski R
    Endocrinology; 1976 Mar; 98(3):598-605. PubMed ID: 1261489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine effects of neuropsychotropic drugs and their possible influence on toxic reactions in animals and man -- the role of the dopamine-prolactin system.
    Horowski R; Gräf KJ
    Arch Toxicol Suppl; 1979; (2):93-104. PubMed ID: 288372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sulpiride on serum growth hormone and prolactin concentrations following L-DOPA administration in man.
    Mori M; Kobayashi I; Shimoyama S; Uehara T; Nemoto T
    Endocrinol Jpn; 1977 Apr; 24(2):149-53. PubMed ID: 406134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    Van Dam LJ; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disorders.
    Bohnet HG; Hanker JP; Horowski R; Wickings EJ; Schneider HP
    Acta Endocrinol (Copenh); 1979 Sep; 92(1):8-19. PubMed ID: 386688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics.
    Horowski R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):147-51. PubMed ID: 36572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.
    Liuzzi A; Chiodini PG; Oppizzi G; Botalla L; Verde G; De Stefano L; Colussi G; Gräf KJ; Horowski R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):196-202. PubMed ID: 108287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics in man of the dopamine antagonist ergot derivative, bromerguride.
    Krause W; Sauerbrey N; Gräf KJ
    Eur J Clin Pharmacol; 1986; 31(2):165-8. PubMed ID: 3803415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
    Hofmann M; Battaini F; Tonon G; Trabucchi M; Spano P
    Eur J Pharmacol; 1979 Jun; 56(1-2):15-20. PubMed ID: 467503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.
    Horowski R; Wachtel H
    Eur J Pharmacol; 1976 Apr; 36(2):373-83. PubMed ID: 945166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with lisuride suppresses prolactin but not thyrotropin secretion.
    Barreca T; Pescatore D; Magnani G; Giberti C; Martorana G; Marabini A; Rolandi E
    Horm Metab Res; 1982 Sep; 14(9):501-2. PubMed ID: 6815043
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel 8 alpha-ergolines with inhibitory and stimulatory effects on prolactin secretion in rats.
    Wachtel H; Dorow R; Sauer G
    Life Sci; 1984 Oct; 35(18):1859-67. PubMed ID: 6492995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.